Monopar Therapeutics (MNPR) Stock Chart & Stock Price History $41.82 -0.14 (-0.33%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Monopar Therapeutics Stock Price Performance 5 Day Performance-2.08%1 Month Performance+3.69%3 Month Performance-1.60%6 Month Performance+185.07%Year-To-Date Performance+90.09%1 Year Performance+1,167.08% Receive MNPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address MNPR Stock Chart for Wednesday, April, 30, 2025 MNPR Chart by TradingView Monopar Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/29/2025$40.81$41.96+2.82%$42.00$39.6219,071 shs$256.50 million04/28/2025$42.71$40.81-4.45%$43.06$39.5620,948 shs$249.47 million04/25/2025$44.57$42.71-4.17%$45.82$41.6716,183 shs$261.09 million04/24/2025$41.47$44.57+7.48%$44.57$39.3513,274 shs$253.49 million04/23/2025$42.96$41.47-3.47%$44.90$40.7211,458 shs$253.51 million04/22/2025$42.71$42.96+0.59%$44.45$42.1917,102 shs$262.61 million04/21/2025$39.59$42.71+7.88%$43.77$38.9014,409 shs$261.09 million04/18/2025$39.59$39.59$40.12$38.7511,576 shs$242.01 million04/17/2025$38.02$39.59+4.13%$40.12$38.7511,576 shs$242.01 million04/16/2025$38.36$38.02-0.89%$38.04$35.5021,214 shs$232.42 million Get the Latest News and Ratings for MNPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/15/2025$37.49$38.36+2.32%$40.90$35.2133,519 shs$234.50 million04/14/2025$34.89$37.49+7.45%$38.00$33.3620,036 shs$229.18 million04/11/2025$31.87$34.89+9.48%$34.98$32.6214,762 shs$213.28 million04/10/2025$32.62$31.87-2.30%$34.30$30.8013,619 shs$194.82 million04/09/2025$28.92$32.62+12.79%$33.38$26.0619,959 shs$199.41 million04/09/2025$28.92$32.62+12.79%$33.38$26.0619,959 shs$199.41 million04/08/2025$28.89$28.92+0.10%$31.10$27.4215,402 shs$176.79 million04/08/2025$28.89$28.92+0.10%$31.10$27.4215,402 shs$176.79 million04/07/2025$30.00$28.89-3.70%$29.51$26.6420,492 shs$176.61 million04/04/2025$34.59$30.00-13.27%$34.86$28.2442,416 shs$183.39 million04/03/2025$38.53$34.59-10.23%$37.99$34.2113,713 shs$211.07 million04/02/2025$33.43$38.53+15.26%$42.00$31.7071,257 shs$235.11 million04/01/2025$36.41$33.43-8.18%$36.46$31.7936,891 shs$203.99 million03/31/2025$40.33$36.41-9.72%$39.51$32.0043,390 shs$222.17 million Related Companies Syndax Pharmaceuticals Stock Price Chart Qilian International Holding Group Stock Price Chart Adaptive Biotechnologies Stock Price Chart Iovance Biotherapeutics Stock Price Chart Wave Life Sciences Stock Price Chart 89bio Stock Price Chart Collegium Pharmaceutical Stock Price Chart Mineralys Therapeutics Stock Price Chart Intellia Therapeutics Stock Price Chart Spyre Therapeutics Stock Price Chart Receive MNPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MNPR) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersTop performing AI play of the decade…? (The answer will shock you)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monopar Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monopar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MNPR Stock Free MNPR Stock Alerts